Filing Details
- Accession Number:
- 0001181431-15-005778
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-13 16:54:37
- Reporting Period:
- 2015-04-09
- Filing Date:
- 2015-04-13
- Accepted Time:
- 2015-04-13 16:54:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885306 | Cynosure Inc | CYNO | Electromedical & Electrotherapeutic Apparatus (3845) | 043125110 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1345794 | J Douglas Delaney | C/O Cynosure, Inc. 5 Carlisle Road Westford MA 01886 | Executive Vp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2015-04-09 | 15,001 | $17.45 | 15,001 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2015-04-09 | 13,334 | $17.61 | 13,334 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2015-04-09 | 28,335 | $33.01 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-04-09 | 15,001 | $0.00 | 15,001 | $17.45 |
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-04-09 | 13,334 | $0.00 | 13,334 | $17.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-05-08 | No | 4 | M | Direct | |
| 0 | 2016-11-20 | No | 4 | M | Direct |
Footnotes
- The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.00 to $33.13 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 5/8/2006 grant date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 11/20/2006 grant date.
Billionaire Hedge Funds
